• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrobial Peptide - Israeli scientists create microbe fighter

Snowy Owl

Retired in 2010, In Memoriam
HAIFA, Israel (UPI) --

Israeli scientists say they`ve found a way to enable an antimicrobial peptide to attack specific common bacteria.

Professor Amram Mor and colleagues at the Technion-Israel Institute of Technology revamped an antimicrobial peptide, a small molecule made of short chains of amino acids, that attacks Pseudomonas aeruginosa -- the bacterium that causes a wide range of infections.

Yet a feature making peptides so useful -- their ability to kill a variety of invaders from bacteria to cancer cells -- makes them hard to deploy against specific infections. Their non-specific action can also destroy normal red blood cells.

Mor and colleagues removed a few amino acids from one end of a dermaseptin peptide and replaced it with a fatty acid molecule. The study showed, for the first time, a fatty acid can replace part of a shortened peptide, which may lower the costs of manufacturing such peptides, according to the researchers.

The change made that particular peptide deadly accurate against P. aerugin,osa, while leaving other bacteria alone. The new peptide was also 60 times less likely to adhere to red blood cells.

The complex research was reported in the Jan. 26 issue of the journal Chemistry and Biology.

Copyright 2007 by United Press International
 
Back
Top